75 related articles for article (PubMed ID: 1028331)
1. [Effect of bis-(p-chlorophenoxy) acetic acid on serum lipids].
Göres E; Rösner G; Spittka K; Kienast S
Acta Biol Med Ger; 1976; 35(12):1745-7. PubMed ID: 1028331
[No Abstract] [Full Text] [Related]
2. [Peroxisome induction with clofibric acid and bis(p-chlorophenoxy)acetic acid (proceedings)].
Zipper J; Janowski K; Göres E
Pharmazie; 1979; 34(5-6):366-7. PubMed ID: 515158
[No Abstract] [Full Text] [Related]
3. [Pharmacologic spectrum of bis(p-chlorphenoxy)acetic acid (proceedings)].
Janowski K; Hagen A; Minenko A; Göres E; Häussner W
Pharmazie; 1979; 34(5-6):365-6. PubMed ID: 515157
[No Abstract] [Full Text] [Related]
4. Hypolipaemic activity of 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate) and its analogues in normolipaemic rats.
Ginocchio AV; Metz G
Arzneimittelforschung; 1980; 30(11b):2032-4. PubMed ID: 7194054
[TBL] [Abstract][Full Text] [Related]
5. Effects of some hypolipidemic agents on biochemical values and hepatic peroxisomal enzymes in rats: comparison of probucol, CGA, KCD-232, MLM-160, AL-369 and clinofibrate with clofibrate.
Watanabe T; Mitsukawa M; Horie S; Suga T; Seki K
J Pharmacobiodyn; 1987 Mar; 10(3):142-7. PubMed ID: 3625448
[TBL] [Abstract][Full Text] [Related]
6. Effects of S-8527 (1,1-bis(4'-(1'-carboxy-1'-methylpropoxy)phenyl) cyclohexane), a new hypolipidemic compound, on cholesterol and lipoprotein metabolism in rats.
Suzuki K
Biochem Pharmacol; 1976 Feb; 25(3):325-8. PubMed ID: 1267828
[No Abstract] [Full Text] [Related]
7. Hypolipemic activity of clofibrate-related compounds.
Metz G; Specker M
Arzneimittelforschung; 1975 Nov; 25(11):1686-92. PubMed ID: 1243074
[TBL] [Abstract][Full Text] [Related]
8. [On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
Schneider J; Mühlfellner G; Mühlfellner O; Hausmann L; Schubotz R
Arzneimittelforschung; 1980; 30(11b):2059-62. PubMed ID: 7194060
[TBL] [Abstract][Full Text] [Related]
9. Effects of S-8527 (1,1-bis4'-(1"-carboxy'1"-methylpropoxy)-phenyl)-cyclohexane), a new hypolipidemic compound, on triglyceride metablolism in rats.
Suzuki K
Biochem Pharmacol; 1975 Jun; 24(11-12):1203-7. PubMed ID: 237511
[No Abstract] [Full Text] [Related]
10. Effects of S-8527 (1, 1-bis (4'-(1"-carboxy-1"-methylpropoxy) phenyl) cyclohexane), a new hypolipidemic compound, on platelet aggregation, adhesiveness and blood coagulation in rats.
Suzuki K
Jpn J Pharmacol; 1975 Aug; 25(4):393-9. PubMed ID: 1206811
[TBL] [Abstract][Full Text] [Related]
11. Effect of SaH 42-348, an analog of clofibrate, on lipid metabolism in rats.
Kritchevsky D; Tepper SA
Arzneimittelforschung; 1973 Jun; 23(6):858-9. PubMed ID: 4740771
[No Abstract] [Full Text] [Related]
12. Evaluation of the hypolipaemic activity of etofylline clofibrate, a new ester of etofylline and clofibric acid, and comparison with effects of known hypolipaemic agents.
Davies JE; Kellett DN
Arzneimittelforschung; 1980; 30(11b):2035-7. PubMed ID: 7194055
[TBL] [Abstract][Full Text] [Related]
13. Effect of miscleron on serum lipid parameters in atherosclerosis induced by cholesterol.
Virág S; Dénes R; Pozsonyi T; Tury K
Ther Hung; 1971; 19(4):148-9. PubMed ID: 4336261
[No Abstract] [Full Text] [Related]
14. Comparison of the effects of halofenate (MK-185) and clofibrate on plasma lipid and uric acid concentration in hyperlipoproteinemic patients.
Lisch HJ; Patsch J; Sailer S; Braunsteiner H
Atherosclerosis; 1975; 21(3):391-9. PubMed ID: 1148032
[TBL] [Abstract][Full Text] [Related]
15. Hypolipemic activity of plafibride.
Bruseghini L; Vilageliu J; Bagaria A
Arzneimittelforschung; 1981; 31(10a):1796-800. PubMed ID: 7198456
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and hypolipidaemic evaluation of a series of alpha-asarone analogues related to clofibrate in mice.
Labarrios F; Garduño L; Vidal MR; Garcia R; Salazar M; Martinez E; Diaz F; Chamorro G; Tamariz J
J Pharm Pharmacol; 1999 Jan; 51(1):1-7. PubMed ID: 10197410
[TBL] [Abstract][Full Text] [Related]
17. Diurnal lipid and lipoprotein profiles with bezafibrate and clofibrate in healthy volunteers.
Oster P; Schlierf G; Lang PD; Mordasini R; Vollmar J
Pharmatherapeutica; 1985; 4(5):267-77. PubMed ID: 4070320
[TBL] [Abstract][Full Text] [Related]
18. Effect of clofibrate on plasma lipid concentration and liver malic enzyme gene expression in rats with experimental chronic renal failure.
Korczyńska J; Stelmańska E; Nieweglowski T; Szołkiewicz M; Rutkowski B; Swierczyński J
Pol J Pharmacol; 2000; 52(4):291-7. PubMed ID: 11345485
[TBL] [Abstract][Full Text] [Related]
19. Effect of clinofibrate on lipid metabolism of aorta in atherosclerotic rats.
Shirai K; Ishikawa Y; Nishide T; Sasaki N; Murano S; Matsuoka N; Saito Y; Yoshida S
Artery; 1983; 12(3):145-55. PubMed ID: 6680996
[TBL] [Abstract][Full Text] [Related]
20. Effects of clofibrate and of an estrogen-progestin combination on fasting biliary lipids and cholic acid kinetics in man.
Pertsemlidis D; Panveliwalla D; Ahrens EH
Gastroenterology; 1974 Apr; 66(4):565-73. PubMed ID: 4821079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]